Filing search / Wave Life Sciences Ltd. / "Investigation" / Page 3

POSASR

EX-5.2

hyf7ma cqnl2k7v24

2 Mar 20

Automatic shelf registration (post-effective amendment)

6:28am

POSASR

69s7t u3n

2 Mar 20

Automatic shelf registration (post-effective amendment)

6:28am

POSASR

EX-5.1

80yxj9t

2 Mar 20

Automatic shelf registration (post-effective amendment)

6:28am

S-8

EX-5.1

bj9jv44u8xsdspw6

5 Nov 19

Registration of securities for employees

5:03pm

S-8

EX-5.1

4w4lcn54

6 Aug 19

Registration of securities for employees

4:53pm

S-3ASR

EX-4.8

x2ctp7o6ay3cfs2tz

10 May 19

Automatic shelf registration

4:20pm

S-3ASR

EX-4.9

sl358wec2

10 May 19

Automatic shelf registration

4:20pm

S-3ASR

bbb9tz3xdi5

10 May 19

Automatic shelf registration

4:20pm

S-3ASR

EX-5.1

66jgumre9hr7yaekd

10 May 19

Automatic shelf registration

4:20pm

S-3ASR

EX-1.2

z17din8epwkhjruwz01f

10 May 19

Automatic shelf registration

4:20pm

S-3ASR

EX-5.2

1cviiq7

10 May 19

Automatic shelf registration

4:20pm

8-K

EX-1.1

kmy00yevu58kuy

24 Jan 19

Wave Life Sciences Prices $150 Million Public Offering of Ordinary Shares

4:34pm

8-K

EX-5.1

8naoahvo ppq

24 Jan 19

Wave Life Sciences Prices $150 Million Public Offering of Ordinary Shares

4:34pm

424B5

pp8ejsqd yem

24 Jan 19

Prospectus supplement for primary offering

4:30pm

424B5

8ue8vrd36cu4 c0bpl

23 Jan 19

Prospectus supplement for primary offering

4:31pm

S-8

EX-5.1

gzv9o87jzky6zcc

9 Nov 18

Registration of securities for employees

4:07pm

8-K

EX-99.2

gohvtz

9 Aug 18

Wave Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update

8:10am